OA04380A - Procédé d'obtention de formes pharmaceutiques retard. - Google Patents

Procédé d'obtention de formes pharmaceutiques retard.

Info

Publication number
OA04380A
OA04380A OA54898A OA54898A OA04380A OA 04380 A OA04380 A OA 04380A OA 54898 A OA54898 A OA 54898A OA 54898 A OA54898 A OA 54898A OA 04380 A OA04380 A OA 04380A
Authority
OA
OAPI
Prior art keywords
obtaining
pharmaceutical forms
depot pharmaceutical
depot
forms
Prior art date
Application number
OA54898A
Other languages
English (en)
French (fr)
Inventor
Claude Mony
Genevieve Coste
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of OA04380A publication Critical patent/OA04380A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
OA54898A 1972-05-10 1973-05-04 Procédé d'obtention de formes pharmaceutiques retard. OA04380A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7216616A FR2183546B1 (xx) 1972-05-10 1972-05-10

Publications (1)

Publication Number Publication Date
OA04380A true OA04380A (fr) 1980-02-15

Family

ID=9098254

Family Applications (1)

Application Number Title Priority Date Filing Date
OA54898A OA04380A (fr) 1972-05-10 1973-05-04 Procédé d'obtention de formes pharmaceutiques retard.

Country Status (17)

Country Link
US (1) US3950508A (xx)
JP (1) JPS5526124B2 (xx)
AR (1) AR203268A1 (xx)
BE (1) BE799331A (xx)
CA (1) CA1041906A (xx)
DD (1) DD104027A5 (xx)
DE (1) DE2323686A1 (xx)
DK (1) DK137706B (xx)
FI (1) FI56623C (xx)
FR (1) FR2183546B1 (xx)
GB (1) GB1421964A (xx)
HU (1) HU168307B (xx)
IL (1) IL42232A (xx)
IN (1) IN139518B (xx)
NL (1) NL158388B (xx)
OA (1) OA04380A (xx)
ZA (1) ZA733188B (xx)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
BR8406921A (pt) * 1983-05-31 1985-06-04 Choong Gook Jang Composicoes secas de compressao,direta para formas de dosagem de liberacao controlada
JPS60104805A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
JPS60104804A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
DE4290300T1 (de) * 1991-01-30 1993-10-07 Wellcome Found Wasserdispergierbare Tabletten
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
AU5681294A (en) * 1992-11-30 1994-06-22 Kv Pharmaceutical Company Tastemasked pharmaceutical materials
IL109460A (en) * 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
IN186245B (xx) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
RS50070B (sr) 1997-12-22 2009-01-22 Euro-Celtique S.A., Oralni dozni oblik sa kombinacijom opijatnog agonista i antagonista
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
ATE493130T1 (de) 2001-05-11 2011-01-15 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
EP1492505B1 (en) * 2002-04-05 2015-06-03 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
US20050019397A1 (en) * 2003-07-23 2005-01-27 Jacobs Richard L. Cellulosic fiber containing composition
DE602005009677D1 (de) * 2004-03-22 2008-10-23 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
BRPI0606339A2 (pt) * 2005-01-28 2009-06-16 Euro Celtique Sa formas farmacêuticas resistentes a álcool
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
BRPI0614914A2 (pt) 2005-07-29 2011-04-19 Solvay Pharm Gmbh processos para a fabricação de pó de pancreatina esterilizada
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
KR20130105935A (ko) * 2008-07-07 2013-09-26 유로-셀티큐 에스.에이. 요폐의 치료를 위한 아편유사제 길항제의 용도
LT2405915T (lt) 2009-03-10 2019-03-12 Euro-Celtique S.A. Greito atpalaidavimo farmacinė kompozicija, apimanti oksikodoną ir naloksoną
AU2014295042B2 (en) 2013-07-23 2017-03-30 Mundipharma Pty Limited A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
FR1473805A (fr) * 1959-10-01 1967-03-24 Merck & Co Inc Véhicule pharmaceutique
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions

Also Published As

Publication number Publication date
FI56623C (fi) 1980-03-10
FI56623B (fi) 1979-11-30
JPS4992217A (xx) 1974-09-03
HU168307B (xx) 1976-03-28
IN139518B (xx) 1976-06-26
CA1041906A (fr) 1978-11-07
JPS5526124B2 (xx) 1980-07-11
AR203268A1 (es) 1975-08-29
NL158388B (nl) 1978-11-15
GB1421964A (en) 1976-01-21
DD104027A5 (xx) 1974-02-20
DK137706C (xx) 1982-11-15
DK137706B (da) 1978-04-24
BE799331A (fr) 1973-11-09
IL42232A0 (en) 1973-07-30
AU5531473A (en) 1974-11-07
DE2323686A1 (de) 1973-11-22
FR2183546B1 (xx) 1975-06-20
US3950508A (en) 1976-04-13
IL42232A (en) 1976-08-31
FR2183546A1 (xx) 1973-12-21
ZA733188B (en) 1975-01-29
NL7306422A (xx) 1973-11-13

Similar Documents

Publication Publication Date Title
OA04380A (fr) Procédé d'obtention de formes pharmaceutiques retard.
FR2284604A1 (fr) Procede de preparation d'a-tocopherol
BE798483A (fr) Procede de preparation d'aldehydes
BE795950A (fr) Procede de preparation d'amidosilanes
OA04511A (fr) Procédé de préparation de 3-hydroxycéphalosporines.
BE789586A (fr) Procede pour la preparation de 3,4,5-trimethoxy-benzaldehyde
BE808733A (fr) Procede de preparation de cyclohexane-diones-1,3
CH554824A (fr) Procede pour la preparation de derives du 1,1-diphenylethylene.
BE807434A (fr) Procede pour la preparation de 3,6-dihalo-diphenyl-alcanes
OA04510A (fr) Procédé de préparation d'éthers d'&-aminoacylcéphalosporine.
BE806124A (fr) Procede de preparation d'hydrazones
RO63792A (fr) Procede pour la preparation d'ergolines-0-6-methyle-2-8-substituees
CH553207A (fr) Procede pour la preparation de derives azotes.
RO64465A (fr) Procede d'obtention de la n-diethyleaminoethyle-2-methoxy-4-amino-5-chlorebenzamide
OA03874A (fr) Procédé d'obtention de nouvelles 7-phénylpyrimido-benzodiazépinones.
RO71515A (ro) Procedeu pentru obtinerea unor derivati ai bis-piperazino-androstanului
BE777069A (fr) Procede d'obtention d'hydrogenochlorosilanes
BE807087A (fr) Procede pour la preparation de thiazolines-(3)
BE807850A (fr) Procede de preparation de nouvelles d'azepines
BE796204A (fr) Procede pour la preparation de 3,4,5,6,7,8-hexahydrocoumarine
RO62774A (fr) Procede pour la preparation des ryphamicynes s.v
BE765103A (fr) Procede pour l'obtention de trinitro 2, 4, 7-fluorenone
OA04432A (fr) Procédé de préparation de 3-amino-pyrazolones-(5).
BE799999A (fr) Procede de preparation d'halogenures d'halogenures d'organo-etains,
BE807995A (fr) Procede de preparation de 1-nitro-anthraquinone pratiquement exempte de 1,5-dinitro-anthraquinone